Dyslipidemia in type 2 diabetic patients with hypertension

Abstract

Objective: to evaluate the dyslipidemia frequency in patients diagnosed with both type 2 diabetes and hypertension.

Methodology: Study was conducted between March 2022 to February 2023 in one year. Patients with type 2 diabetes and hypertension, with high blood pressure (130/80 mmHg), presented at outpatient department were enrolled.  Dyslipidemia is diagnosed based on a laboratory report indicating elevated serum cholesterol levels exceeding 180 mg/dl, serum triglyceride levels surpassing 150 mg/dl, and low HDL cholesterol levels below 40 mg/dl in males and 50 mg/dl in females during fasting lipid profile testing.

Results: dyslipidemia presence in 80.7% of patients, with 57.2% showing increased cholesterol levels and 70.3% having elevated triglycerides. Additionally, 80% of patients exhibited low high-density lipids.

Conclusion: Patients with Type 2 diabetic combined with hypertension are at a heightened risk of developing dyslipidemia, with the most common abnormal finding in their lipid profile being a low level of high-density lipids (HDL).